Postoperative adjuvant therapy of rectal cancer: An analysis of disease control, survival, and prognostic factors
β Scribed by Steven E. Schild; James A. Martenson Jr.; Leonard L. Gunderson; Duane M. Ilstrup; Kathryn K. Berg; Michael J. O'Connell; Louis H. Weiland
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 938 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Current adjuvant hormone therapy in postmenopausal women with breast cancer is debatable between upfront aromatase inhibitors (AIs) and sequential treatment with tamoxifen. A major concern is the higher rate of early recurrences observed with sequential treatment. The aut
Fifty evaluable, previously untreated, adult patients with clinically staged (CS) early and advanced Hodgkin's disease were treated with chemotherapy alone, using various re ihad CS I or II and 35 (70%) had CS 111 or IV. Eighty-eight per cent of patients had one or more of the B symptoms and 64% had
The purpose of this study was to investigate pretreatment variables that could predict prognosis and to evaluate the impact of postoperative adjuvant therapy on the outcomes of patients with Stage IB or II cervical carcinoma with or without pelvic lymph node metastases.